Ultromics Company
They are building world-class diagnostic aids to help cardiologists вАФ powered by artificial intelligence. To date, they have developed the worldвАЩs most accurate echocardiography software to improve the diagnosis of coronary heart disease by more than 90%.
Investors
%20.png)
Estimated Revenue:
$1M to $10M
Funding Status:
Early Stage Venture
Industry:
Imaging
Investors Number:
13
Last Funding Date:
2021-08-16
Technology:
HealthCare Administration
Founded Date:
2017-01-01
Headquarters:
Oxford, Oxfordshire, United Kingdom
Total Funding:
58824943
Last Funding Type:
Series B
Employee Number:
11-50